Clinical trial
The COVID-19 and Cancer Consortium (CCC19) Registry
NCT04354701 is registered in ClinicalTrials.gov with Vanderbilt-Ingram Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The COVID-19 and Cancer Consortium (CCC19) Registry
- Lead sponsor
- Vanderbilt-Ingram Cancer Center
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- March 17, 2020
- Completion date
- December 31, 2029
- Enrollment
- 19,275 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19, invasive malignancy (any type)